Elena N. Nikulkina

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Letter to the editor: High rate of clinical and immunological response in patients with HCV-associated cryoglobulinemia.

Letter to the editor: High rate of clinical and immunological response in patients with HCV-associated cryoglobulinemia.

Journal: Hepatology (Baltimore, Md.)

Published: February 09, 2022

Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.

Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.

Journal: Clinics and research in hepatology and gastroenterology

Published: January 29, 2021

Visceral leishmaniasis: a challenging diagnosis in internal medicine

Visceral leishmaniasis: a challenging diagnosis in internal medicine

Journal: Terapevticheskii arkhiv

Published: December 26, 2020

The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus

The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus

Journal: Terapevticheskii arkhiv

Published: April 26, 2020

Antiviral therapy of chronic hepatitis C: 30 years success story

Antiviral therapy of chronic hepatitis C: 30 years success story

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?

Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?

Journal: Journal of hepatology

Published: March 16, 2020

Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B.

Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B.

Journal: Terapevticheskii arkhiv

Published: May 17, 2019

Risk factors of unfavorable prognosis of chronic hepatitis C.

Risk factors of unfavorable prognosis of chronic hepatitis C.

Journal: Terapevticheskii arkhiv

Published: May 17, 2019

Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review).

Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review).

Journal: Terapevticheskii arkhiv

Published: May 16, 2019

Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Journal: Antiviral therapy

Published: October 10, 2018

Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance.

Journal: Antiviral therapy

Published: September 16, 2018

HBsAg levels as a guide for finite treatment duration of chronic hepatitis B.

HBsAg levels as a guide for finite treatment duration of chronic hepatitis B.

Journal: Clinics and research in hepatology and gastroenterology

Published: September 04, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026